期刊文献+

大剂量阿托伐他汀治疗老年心肌梗死患者的临床疗效观察

Clinical curative effect observation of high-dose atorvastatin in the treatment of elderly patients with myocardial infarction
下载PDF
导出
摘要 目的:探讨阿托伐他汀治疗老年心肌梗死患者的临床疗效。方法:收治老年心肌梗死患者90例,随机分为观察组和对照组。两组均给予常规治疗,观察组加用阿托伐他汀。结果:观察组TG、TC、LDL-C、LVDD、IVST、LVMI水平均低于对照组,不良反应发生率低于对照组。结论:阿托伐他汀治疗老年心肌梗死患者的疗效确切。 Objective:To explore the clinical curative effect of atorvastatin in the treatment of elderly patients with myocardial infarction.Methods:90 cases of elderly patients with myocardial infarction were divided into the observation group and the control group randomly.The two groups were given conventional treatment and the observation group were added with atorvastatin.Results:The TG,TC,LDL-C,LVDD,IVST,LVMI levels of the observation group were lower than those of the control group,and the incidence of adverse reaction was lower than that of the control group.Conclusion:Atorvastatin in the treatment of elderly patients with myocardial infarction had curative effect.
作者 马飞
出处 《中国社区医师》 2015年第17期21-21,24,共2页 Chinese Community Doctors
关键词 心肌梗死 阿托伐他汀 不良反应 Myocardial infarction Atorvastatin Adverse reaction
  • 相关文献

参考文献3

二级参考文献22

  • 1戚文航.血管紧张素受体拮抗剂与心房颤动[J].中华心血管病杂志,2004,32(11):1042-1043. 被引量:93
  • 2Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:346
  • 3李楠,王枢传.肺动脉高压的研究进展[J].国际呼吸杂志,2007,27(15):1188-1192. 被引量:5
  • 4Robertson L,Grip L,Mausson Hult(e)n L,el al. Release of protein as well as activity of MMP-9 from unstable athleroclerotic plaques during percutaneous coronary intervention[J].Journal of Internal Medicine,2007,(06):659-667.
  • 5Zallsman A B,Ne wby A C. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits;relationship to lesion severity[J].Atheroclerosis,1997,(07):61-70.
  • 6Galis Z S,Sukhova G K,Lark M W. Increased expression of matrix metall oproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques[J].Journal of Clinical Investigation,1994,(06):2493-2503.
  • 7Ross R. The pathogenesis of atherosclerosis:a perspective for the 1990[J].Nature,1993,(03):801-809.
  • 8Libby P,Ridker P M,Maseri A. Inflammation and atherosclerosis[J].Circulation,2002,(08):1135-1143.
  • 9Mallat Z,Corbaz A,Scoazec A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability[J].Circulation,2001,(14):1598-1603.
  • 10Empana J P,Canou-iPoitrine F,Luc G. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome;the PRIME study[J].European Heart Journal,2008,(16):1966-1977.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部